SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001576885-23-000062
Filing Date
2023-11-13
Accepted
2023-11-13 16:21:48
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abos-20230930.htm   iXBRL 10-Q 826857
2 EX-31.1 abos-20230930x10qxexx311.htm EX-31.1 10631
3 EX-31.2 abos-20230930x10qxexx312.htm EX-31.2 10649
4 EX-32.1 abos-20230930x10qxexx321.htm EX-32.1 5042
5 EX-32.2 abos-20230930x10qxexx322.htm EX-32.2 5071
  Complete submission text file 0001576885-23-000062.txt   4699987

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abos-20230930.xsd EX-101.SCH 32771
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abos-20230930_cal.xml EX-101.CAL 61644
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abos-20230930_def.xml EX-101.DEF 152417
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abos-20230930_lab.xml EX-101.LAB 460063
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abos-20230930_pre.xml EX-101.PRE 289544
50 EXTRACTED XBRL INSTANCE DOCUMENT abos-20230930_htm.xml XML 607621
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 231399112
SIC: 2836 Biological Products, (No Diagnostic Substances)